Year : 2010
Number of
Pages : 46 leaves
Adviser : Prof. Glen A. Imbang
Executive
Summary
The
Republic Act 10055 or the Philippine Technology Transfer Act of 2009 was
enacted to address the technology transfer concerns of most research
institutions in the country. According to the Philippine Council for
Agriculture, Forestry and Natural Resources Research and Development (PCARRD),
the country's technology transfer system is characterized by : lack of
well-defined and unifying policy on technology transfer insufficient investment
in technology transfer and commercialization weak private-public collaboration
in R&D and commercialization and lack of well-defined IP regimes in R&D
institutions. The Implementing Rules and Regulations (IRR) of the law requires
that guidelines on IP valuation, commercialization and information sharing
should be developed to assist the science and research community in their
endeavor to transfer promising technologies they developed. The Philippine Council
for Industry and Energy Research and Development (PCIERD) experience on
technology transfer started in 1999 when Moondish Foods Corp. (MFC) entered
into a licensing agreement for the manufacture and marketing of Food and
Nutrition Research Institute (FNRI) and PCIERD-developed technology-the
"Canned Laing". Since it was their first time to license a
technology, they agreed on a royalty rate of 3 percent of the gross sales,
which they thought were fair to both parties. In the first few years of operation,
MFC experienced losses and waived the payment of royalties. It was only in
2004, that MFC gained market acceptance and successfully penetrated the US, UK,
Middle East and Canada markets. In 2008, MFC gain signed a technology transfer
agreement (TTA) with FNRI and PCIERD to adopt another ethnic food product- the
"Canned Pinakbet". The parties agreed for a 2 percent (of the gross
sales) royalty, which is lower than the Canned laing rate. The MFC requested to
lower the rate based on their experience when they first introduced the Canned
Laing. The Council's licensing set-up shows that there is no available
technology valuation system that will support its licensing activities. The
lack of a valuation tool and information on the market and potential value of a
technology sometimes delays and discourages the negotiation and licensing
process. Furthermore, the potential value of a technology is not taken into
consideration, hence this project. The project is on the adoption of a
valuation model of the Ocean Tomo Intellectual Capital Equity to determine the
value of two (2) PCIERD-assisted and monitored technologies-the "Microbial
Rennet Technology" and the "Vitamin-rich Green Mango Juice".
Ocean Tomo is the leading merchant bank based in Chicago and a well known IP
valuation company in the U.S. The valuation model adopted is an "income
approach" of valuation. It consists of five (5) main activities :
Intellectual Property (IP) Identification, Assessment of Competitive Advantage,
Market Quantification, Value Allocation and Risk Adjustments. The first phase
of the project was identification of intellectual property (IP). Interviews
with the technology developers and project monitors were conducted to gather
information about the technology. Technology information was presented in the
Technology Summary Form (TSF). The second phase was the conduct of technology
assessment with the technical monitors and financial/marketing analyst to
determine the readiness of technology for commercialization. The project made
use of the existing Technology Assessment Protocol (TAP) of PCIERD and the
Heslop et al Cloverleaf Model of Technology Transfer for the TEEPS scoring. The
third phase focused is market quantification where the overall market,
segmented market and the attackable market were determined based on industry
data and market assumptions.
The
fourth phase of the valuation process dealt with value allocation where royalty
revenues were computed using several assumptions on the expected useful life of
the technology, launch date, penetration rate, and ramp-up timeframe (time to
reach maximum penetration). The last phase of the valuation was on risk
adjustments where the royalty revenues were discounted with risk factors based
on Razgaitis" Risk Adjusted Hurdle Rates (RAHR) to determine the net
present value of the technology. Like any other activities involving the
future, the technical risks, market risks, competitive risks and legal risks
were taken into account in the conduct of valuation. Information generated from
the process were presented in the valuation template developed. The template
consists of the Cover, Valuation Summary, Technology Summary Form, Technology
Assessment/Report, Target Market Profile, Valuation and Industry Study. The
valuation template developed is recommended for use by PCIERD during licensing
negotiations as it provides information about the technology, target market
profile, market potential, industry performance and expected returns at
different royalty rates. Though it has been established that the income
approach to technology valuation is appropriate for PCIERD technologies, the
challenge of integrating the activity in the technology transfer system of the
Council as well as its capability to undertake the activity needs to be
assessed. Given the fact that there is no exact formula for valuation, the
Council should be aware that the resulting values are just near estimates of
the potential value of the technology and still dependent on the assumptions
and method used by the Valuators.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.